{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:42:51Z","timestamp":1793317371252,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.vaccine.2024.126316","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T07:48:11Z","timestamp":1726732091000},"page":"126316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Relative effectiveness of adjuvanted versus non-adjuvanted influenza vaccines in older adults with risk factors for influenza complications during the 2019\u20132020\u00a0U.S. influenza season"],"prefix":"10.1016","volume":"42","author":[{"given":"Mahrukh","family":"Imran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly W.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Bogdanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"McGovern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mendel","family":"Haag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126316_bb0015","first-page":"1601","article-title":"High clinical burden of influenza disease in adults aged \u226565 years: can we do better?","volume":"40","author":"Langer","year":"2023","journal-title":"A systematic literature review Adv Ther"},{"key":"10.1016\/j.vaccine.2024.126316_bb0020","article-title":"Age-related differences in hospitalization rates, clinical presentation, and outcomes among older adults hospitalized with influenza\u2014U.S. influenza hospitalization surveillance network (FluSurv-NET). Open forum","volume":"6","author":"Czaja","year":"2019","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2024.126316_bb0030","article-title":"The number of influenza risk factors informs an adult\u2019s increased potential of severe influenza outcomes: a multi-season cohort study from 2015 to 2020. Open forum","author":"McGovern","year":"2024","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2024.126316_bb0035","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126316_bb0040","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1016\/j.vaccine.2013.09.063","article-title":"Cochrane re-arranged: support for policies to vaccinate elderly people against influenza","volume":"31","author":"Beyer","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126316_bb0045","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/ni.2588","article-title":"Understanding immunosenescence to improve responses to vaccines","volume":"14","author":"Goronzy","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2024.126316_bb0050","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/21645515.2017.1338547","article-title":"Factors affecting immune responses to the influenza vaccine","volume":"14","author":"Castrucci","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.126316_bb0055","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF03324904","article-title":"Immunosenescence and vaccine failure in the elderly","volume":"21","author":"Grubeck-Loebenstein","year":"2009","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.vaccine.2024.126316_bb0060","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1750-2659.2008.00059.x","article-title":"MF59\u00ae-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis","volume":"2","author":"Banzhoff","year":"2008","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2024.126316_bb0065","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1016\/j.vaccine.2011.09.061","article-title":"The mechanism of action of MF59 - an innately attractive adjuvant formulation","volume":"30","author":"O\u2019Hagan","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126316_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2019.110632","article-title":"Immunosenescence: a systems-level overview of immune cell biology and strategies for improving vaccine responses","volume":"124","author":"Crooke","year":"2019","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.vaccine.2024.126316_bb0080","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.3390\/vaccines10091456","article-title":"Relative vaccine effectiveness of adjuvanted trivalent influenza vaccine over three consecutive influenza seasons in the United States","volume":"10","author":"Boikos","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2024.126316_bb0085","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3390\/vaccines9080862","article-title":"Effectiveness of the adjuvanted influenza vaccine in older adults at high risk of influenza complications","volume":"9","author":"Boikos","year":"2021","journal-title":"Vaccines-Basel"},{"key":"10.1016\/j.vaccine.2024.126316_bb0090","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/irv.12871","article-title":"Effectiveness of the MF59-adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta-analysis","volume":"15","author":"Coleman","year":"2021","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2024.126316_bb0095","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.vaccine.2016.12.011","article-title":"Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: a systematic review and meta-analysis","volume":"35","author":"Domnich","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126316_bb0100","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3390\/vaccines9080862","article-title":"Effectiveness of the adjuvanted influenza vaccine in older adults at high risk of influenza complications","volume":"9","author":"Boikos","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.126316_bb0105","first-page":"18","article-title":"2019\u20132020 Influenza Vaccine Update","volume":"44","author":"Yung","year":"2019","journal-title":"US Pharm"},{"key":"10.1016\/j.vaccine.2024.126316_bb0110","article-title":"2019\u20132020 H1N1 clade A5a.1 viruses have better in vitro fitness compared with the co-circulating A5a.2 clade","volume":"13","author":"Swanson","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2024.126316_bb0115","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3390\/vaccines10050727","article-title":"Integrating electronic medical records and claims data for influenza vaccine research","volume":"10","author":"Boikos","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.126316_bb0120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/pds.3891","article-title":"International Society of Pharmacoepidemiology. Guidelines for good pharmacoepidemiology practice (GPP)","volume":"25","author":"Public Policy Committee","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2024.126316_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies conducted using observational routinely-collected health data (RECORD) statement","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2024.126316_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6803a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices \u2014 United States, 2019\u201320 influenza season","volume":"68","author":"Grohskopf","year":"2019","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2024.126316_bb0135","first-page":"2","article-title":"Assessment of ICD-9-based case definitions for influenza-like illness surveillance","volume":"22","author":"Eick-Cost","year":"2015","journal-title":"MSMR"},{"key":"10.1016\/j.vaccine.2024.126316_bb0140","series-title":"Armed forces health surveillance center (AFHSC). Influenza-like illness (ILI)","year":"2015"},{"key":"10.1016\/j.vaccine.2024.126316_bb0145","author":"United States Census Bureau"},{"key":"10.1016\/j.vaccine.2024.126316_bb0155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/pds.3719","article-title":"Using claims data to predict dependency in activities of daily living as a proxy for frailty","volume":"24","author":"Faurot","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2024.126316_bb0160","doi-asserted-by":"crossref","DOI":"10.1111\/irv.13288","article-title":"Relative effectiveness of the MF59\u00ae-adjuvanted influenza vaccine versus high-dose and non-adjuvanted influenza vaccines in preventing cardiorespiratory hospitalizations during the 2019-2020 US influenza season","volume":"18","author":"Imran","year":"2024","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2024.126316_bb0165","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1541-0420.2005.00377.x","article-title":"Doubly robust estimation in missing data and causal inference models","volume":"61","author":"Bang","year":"2005","journal-title":"Biometrics"},{"key":"10.1016\/j.vaccine.2024.126316_bb0170","first-page":"1057","article-title":"Centers for Disease Control and Prevention (CDC). Estimates of deaths associated with seasonal influenza --- United States, 1976\u20132007","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.126316_bb0180","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S1473-3099(16)00129-8","article-title":"Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies","volume":"16","author":"Belongia","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126316_bb0185","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/cid\/ciaa407","article-title":"Influenza vaccine effectiveness in inpatient and outpatient settings in the United States, 2015\u20132018","volume":"73","author":"Tenforde","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126316_bb0190","doi-asserted-by":"crossref","first-page":"177","DOI":"10.15585\/mmwr.mm6907a1","article-title":"Interim estimates of 2019-20 seasonal influenza vaccine effectiveness - United States, February 2020","volume":"69","author":"Dawood","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.126316_bb0195","doi-asserted-by":"crossref","first-page":"e4244","DOI":"10.1093\/cid\/ciaa1884","article-title":"Effect of antigenic drift on influenza vaccine effectiveness in the United States\u20142019\u20132020","volume":"73","author":"Tenforde","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126316_bb0200","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1016\/j.vaccine.2015.06.101","article-title":"The weight of obesity on the human immune response to vaccination","volume":"33","author":"Painter","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126316_bb0205","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1001\/jama.1997.03540450065037","article-title":"Determination of deltoid fat pad thickness: implications for needle length in adult immunization","volume":"277","author":"Poland","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2024.126316_bb0210","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5430\/jnep.v8n2p83","article-title":"Evidence calls for practice change in intramuscular injection techniques","volume":"8","author":"Strohfus","year":"2017","journal-title":"J Nursing Educ Practice"},{"key":"10.1016\/j.vaccine.2024.126316_bb0215","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1016\/j.vaccine.2021.06.081","article-title":"Inadequate deltoid muscle penetration and concerns of improper COVID mRNA vaccine administration can be avoided by injection technique modification","volume":"39","author":"Rahamimov","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126316_bb0220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.vaccine.2021.11.008","article-title":"A long shot: the importance of needle length in vaccinating patients with obesity against COVID-19","volume":"40","author":"Chhabria","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126316_bb0225","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.apnr.2013.09.002","article-title":"Are im injections im in obese and overweight females? A study in injection technique","volume":"26","author":"Palma","year":"2013","journal-title":"Appl Nurs Res"},{"key":"10.1016\/j.vaccine.2024.126316_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7202a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices \u2014 United States, 2023\u201324 influenza season","volume":"72","author":"Grohskopf","year":"2023","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2024.126316_bb0235","doi-asserted-by":"crossref","first-page":"2257048","DOI":"10.1080\/21645515.2023.2257048","article-title":"The burden of influenza and the role of influenza vaccination in adults aged 50-64 years: a summary of available evidence","volume":"19","author":"Marchi","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.126316_bb0240","doi-asserted-by":"crossref","DOI":"10.1111\/irv.13054","article-title":"Prevalence of chronic conditions and influenza vaccination coverage rates in Germany: results of a health insurance claims data analysis","volume":"17","author":"Damm","year":"2023","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2024.126316_bb0245","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae180","article-title":"Incidence of influenza-related medical encounters and the associated healthcare resource use and complications across adult age groups in the United States during the 2015-2020 influenza seasons","author":"McGovern","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126316_bb0250","article-title":"Burden of severe illness associated with laboratory-confirmed influenza in adults aged 50-64 years, 2010-2011 to 2016-2017. Open forum","volume":"10","author":"Kim","year":"2023","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2024.126316_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201348","article-title":"Health seeking behavior as a predictor of healthcare utilization in a population of patients with spinal pain","volume":"13","author":"Clewley","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.126316_bb0265","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1186\/s12888-021-03435-4","article-title":"Predictors of help-seeking behaviour in people with mental health problems: a 3-year prospective community study","volume":"21","author":"Doll","year":"2021","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.vaccine.2024.126316_bb0270","first-page":"22","article-title":"Demystifying double robustness: a comparison of alternative strategies for estimating a population mean from incomplete data","author":"Kang","year":"2007","journal-title":"Stat Sci"},{"key":"10.1016\/j.vaccine.2024.126316_bb0275","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ckj\/sfab158","article-title":"An introduction to inverse probability of treatment weighting in observational research","volume":"15","author":"Chesnaye","year":"2022","journal-title":"Clin Kidney J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24009988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24009988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T17:41:41Z","timestamp":1741887701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24009988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":48,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0264410X24009988"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126316","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relative effectiveness of adjuvanted versus non-adjuvanted influenza vaccines in older adults with risk factors for influenza complications during the 2019\u20132020\u00a0U.S. influenza season","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126316","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126316"}}